Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
Yuzhuo LiJing LiMiaohan QiuSicong MaKun NaXiaoying LiZizhao QiSanbao ChenYi LiYa-Ling HanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
Whilst the risk of major bleeding was comparable between the two drugs, ticagrelor was associated with a significantly lower risk of ischemic events than clopidogrel in ACS patients undergoing complex PCI.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- patients undergoing
- coronary artery bypass grafting
- coronary artery disease
- atrial fibrillation
- coronary artery bypass
- cerebral ischemia
- subarachnoid hemorrhage